ExactAntigen

progesterone receptor antibody | antibody review based on formal publications
PGR antibodies
This is a review about progesterone receptor antibodies, based on 20 published articles using progesterone receptor antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited progesterone receptor antibody.
Sigma-Aldrich    search Sigma-Aldrich PGR products
ihSigma PGR antibody was tested in immunohistochemistry by Human Protein Atlas. to the paper
Santa Cruz Biotechnology    search Santa Cruz Biotechnology PGR products
ihSanta Cruz Biotechnology rabbit polyclonal anti-PR antibody was used in immunohistochemistry to detect PR in the human specimens of a section of a seminiferous tubule adjacent to a seminoma or a section of a seminoma. to the paper
Millipore    search Millipore PGR products
wbUpstate anti-PR antibody was used in western blot to study Nm23-H1 expression in hormone receptor–negative breast cancer. to the paper
ihChemicon monoclonal anti-progesterone receptor antibody MAB429 was used in immunohistochemistry to study the steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma. to the paper
ihChemicon monoclonal antibody for progesterone receptor was used in immunohistochemistry to study the biological significance of estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. to the paper
VENTANA MEDICAL SYSTEMS
ihVentana Medical Systems rabbit polyclonal anti-progesterone receptor (PgR) antibody was used in paraffin sections from human breast cancer and in immunohistochemistry to study the role of 17ß-estradiol for down-regulation of Cap43/NDRG1/Drg-1 in human breast cancer cells. to the paper
NOVOCASTRA
ihNovocastra PGR antibody was tested in immunohistochemistry by HPA (CAB000068) . to the paper
wbNovocastra Laboratories anti-progesterone receptor (1:50) antibody was used in western blot to study the regulation of steroidogenic acute regulatory protein expression by imitation switch protein SNF2L during terminal differentiation of ovarian granulosa cells. to the paper
ihNovocastra Laboratories monoclonal anti-progesterone receptor[PR (NCL-PGR)] antibody(1A6) was used in immunohistochemistry to study whether levels of ANX7 correlate with breast cancer progression and survival in paraffin sections from human tumor. to the paper
BIOGENEX
ihBioGenex anti-human progesterone receptor (PR) antibody was used in paraffin sections from human breast cancer and in immunohistochemistry to study the role for IL-6 in driving Stat3 activation in breast cancer. to the paper
ihBioGenex mouse monoclonal anti-PR antibody (clone PR88) was used in immunohistochemistry to study nuclear localization of KLF4 in early-stage breast cancer. to the paper
ihBiogenex monoclonal anti-progesterone receptor antibody was used in immunohistochemistry to detect progesterone receptor in tumor tissue from patients with breast cancer. to the paper
LAB VISION CORP
ihLab Vision Corp anti-PR antibody was used in immunohistochemistry to study the coordinate expression of Cdc25B and the role of ER-alpha in high-grade endometrioid and nonendometrioid carcinomas. to the paper
LAB VISION
wbLab Vision Progesterone Receptor (PgR) Ab-2 antibody was tested in western blot by Abminer . to the paper
DAKO
ihDAKO anti-progesterone receptor antibody 636 was used in immunohistochemistry to study the association of α-Methylacyl-CoA racemase protein expression with the degree of differentiation in breast cancer. to the paper
ihDako monoclonal anti-progesterone receptor (PgR) antibody was used in paraffin sections from human normal 、pathological breast tissue and in immunohistochemistry to study the fuction of HMGA1 protein expression for the diagnosis and prognosis of human breast cancer. to the paper
wbDako mouse anti-PgR antibody was used in western blot to detect PgR in protein extract of a cohort of frozen primary breast tumor specimens from 305 axillary lymph node-positive patients. to the paper
ihDAKO anti-PgR antibody was used in immunohistochemistry to study HDAC6 expression and its correlation with better survival rates in breast cancer. to the paper
ihDako anti-progesterone receptor antibody was used in immunohistochemistry to detect progesterone receptor in invasive lobular carcinoma breast tumor sections. to the paper
ihDako anti-progesterone receptor antibody was used in immunohistochemistry to detect progesterone receptor in adjacent serial sections of two breast invasive ductal carcinomas from patients. to the paper
ihDako mouse monoclonal anti-PgR antibody (clone 1A6) was used in paraffin sections from human cancer and in immunohistochemistry to study the effect of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. to the paper
Articles Reviewed
1:Marjan Berishaj et al. Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer. 2007
2:Maribeth A Lazzaro et al. The imitation switch protein SNF2L regulates steroidogenic acute regulatory protein expression during terminal differentiation of ovarian granulosa cells. 2006
3:Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006
4:Anja Persson et al. A human protein atlas based on antibody proteomics. 2006
5:Abbas Fotovati et al. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells. 2006
6:Diane Palmieri et al. Medroxyprogesterone acetate elevation of Nm23-H1 metastasis suppressor expression in hormone receptor-negative breast cancer. 2005
7:Agnieszka K Witkiewicz et al. Alpha-methylacyl-CoA racemase protein expression is associated with the degree of differentiation in breast cancer using quantitative image analysis. 2005
8:Ashka Y Pandya et al. Nuclear localization of KLF4 is associated with an aggressive phenotype in early-stage breast cancer. 2004
9:Daniel G Hayward et al. The centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancer. 2004
10:Zhenhuan Zhang et al. HDAC6 expression is correlated with better survival in breast cancer. 2004
11:Majida Esslimani-Sahla et al. Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer. 2004
12:Torsten A Hopp et al. Low levels of estrogen receptor beta protein predict resistance to tamoxifen therapy in breast cancer. 2004
13:Gennaro Chiappetta et al. HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression. 2004
14:Hiroki Utsunomiya et al. Steroid sulfatase and estrogen sulfotransferase in human endometrial carcinoma. 2004
15:Anna Maria Granato et al. Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?. 2004
16:Takashi Suzuki et al. Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. 2004
17:Meera Srivastava et al. Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients. 2004
18:Weiguo Wu et al. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas. 2003
19:Andrea Decensi et al. A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkers. 2003
20:Vernon Pais et al. Estrogen receptor-beta expression in human testicular germ cell tumors. 2003


2008©ExactAntigen home | browse | about